Baird Medical Investment Holdings Limited (BDMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Baird Medical Investment Holdings Limited (BDMD) has a cash flow conversion efficiency ratio of -0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.19 Million) by net assets ($35.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BDMD equity financing ratio to measure how much of total assets are equity-financed.
Baird Medical Investment Holdings Limited - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Baird Medical Investment Holdings Limite to evaluate the quality of earnings relative to operating cash generation.
Baird Medical Investment Holdings Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baird Medical Investment Holdings Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Piolink Inc
KQ:170790
|
0.042x |
|
PT Sarimelati Kencana Tbk
JK:PZZA
|
0.075x |
|
Carnival PLC
LSE:CCL
|
0.096x |
|
Inbest Prime IV Inmuebles SOCIMI S.A.
MC:YINB4
|
N/A |
|
Advanced Braking Technology Ltd
AU:ABV
|
0.134x |
|
Apollo Sindoori Hotels Limited
NSE:APOLSINHOT
|
0.001x |
|
Europacorp
PA:ALECP
|
-1.391x |
|
EYG Gayrimenkul Yatirim Ortakligi A.S.
IS:EYGYO
|
0.020x |
Annual Cash Flow Conversion Efficiency for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual cash flow conversion efficiency of Baird Medical Investment Holdings Limited from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see BDMD market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $39.76 Million | $-6.31 Million | -0.159x | -455.86% |
| 2023-12-31 | $35.71 Million | $-1.02 Million | -0.029x | -251.52% |
| 2022-12-31 | $25.78 Million | $485.97K | 0.019x | -94.31% |
| 2021-12-31 | $15.86 Million | $5.26 Million | 0.331x | -42.65% |
| 2020-12-31 | $6.76 Million | $3.91 Million | 0.578x | +395.65% |
| 2019-12-31 | $-22.58 Million | $4.41 Million | -0.195x | -- |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more